1.Effect of aorta-iliac bypass total thoracoabdominal aorta aneurysm repair to spinal cord function.
Yuyin DUAN ; Jun ZHENG ; Xudong PAN ; Junming ZHU ; Yongmin LIU ; Yipeng GE ; Lijian CHENG ; Lizhong SUN
Chinese Journal of Surgery 2016;54(5):380-383
OBJECTIVETo evaluate the effect of aorta-iliac bypass total thoracoabdominal aorta aneurysm repair to spinal cord function.
METHODSThis was a prospective study. From June 2014 to April 2015, 31 patients underwent total thoracoabdominal aorta aneurysm repair were treated with aorta-iliac bypass technique. There were 23 male and 8 female patients with a mean age of (36±12) years. A 4-branched tetrafurcate graft was used. The aorta-iliac bypass was established, then distal descending aorta was perfused in a retrograde fashion via bypass graft. Thoracic and abdominal aorta were replaced in a staged fashion. Evoked potentials (EP) monitoring was adopted to assess the spinal cord ischemia throughout the procedure. The intraoperative evoked potentials results, clinical outcomes and follow-up results of this technique were evaluated.
RESULTSThe EP wave disappeared after proximal descending aorta clamped and gradually recovered after the patent segmental arteries reattached. Motor evoked potentials disappeared for (56±18) minutes, somatosensory evoked potentials disappeared for (50±19) minutes. The EP wave was restored to normal at the end of operation in all cases. The somatosensory evoked potentials remained unchanged in 2 cases (false negative). One case died after operation. There were acute kidney dysfunction in 3 cases, and pulmonary haemorrhage in 1 case. No spinal cord injure occurred. The median follow-up after operation was 8 months (ranging from 1 to 11 months). There was no delayed neurologic deficit or relative death.
CONCLUSIONSThere is a transient function loss of spinal cord during the aorta-iliac bypass total thoracoabdominal aorta aneurysm repair. But the process is reversible. The technique of the aorta-iliac bypass is practicable.
Adult ; Aorta, Abdominal ; surgery ; Aortic Aneurysm, Abdominal ; surgery ; Aortic Aneurysm, Thoracic ; surgery ; Evoked Potentials, Motor ; Evoked Potentials, Somatosensory ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Spinal Cord ; physiopathology ; Vascular Surgical Procedures ; adverse effects
2.Quality Evaluation of Domestic Pharmacoeconomic Literatures Based on PEERs in Recent Years
Hailiang GAO ; Tingting JIANG ; Cong ZHANG ; Mengpei ZHANG ; Haoxiang ZHANG ; Zhiheng WANG ; Lizhong DUAN ; Wentao ZHU
China Pharmacy 2019;30(10):1393-1395
OBJECTIVE: To investigate current status and quality of domestic pharmacoeconomic literatures, and to provide reference for the standardization of pharmacoeconomic research. METHODS: Retrieved from CNKI, Wanfang, VIP and other database, the pharmacoeconomic literatures published from Jan. 2017 to May 2018 were collected. The qualities of literatures were evaluated with Guidelines for Quality Evaluation of Pharmacoeconomics Evaluation Reports (“PEERs” for short). RESULTS: Totally 160 domestic pharmacoeconomic research literatures were included. The results of PEERs evaluation showed of which the coincidence rate was 32.5% (52/160). The literatureswhich were in full compliance (the report had a certain reference value) accounted for 1.3% (2/160), which were in basic compliance (the report had certain reference value after being revised) accounted for 31.3%(50/160),which were in non-conformity (the report did not had reference value) accounted for 67.5%(108/160). Domestic pharmacoeconomic researches were of high quality in terms of research object, evaluation method and content,research purpose, research design and design type, etc.; but the researches were of low quality in terms of research angle, incremental cost/incremental output analysis, sensitivity analysis and other aspects, and there was no explanation or unclear elaboration. CONCLUSIONS: The quality of domestic pharmacoeconomic research literatures are uneven, and their research quality needs to be further improved. It is recommended to standardize the evaluation of pharmacoeconomics, making the evaluation of pharmacoeconomics more scientific and objective.